SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-024768
Filing Date
2020-09-01
Accepted
2020-09-01 15:47:08
Documents
2
Period of Report
2020-09-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1599
2 POWER OF ATTORNEY ea126258ex24-1_cmlifescience.htm EX-24.1 11048
  Complete submission text file 0001213900-20-024768.txt   13982
Mailing Address 458 BRANNAN STREET SAN FRANCISCO CA 94107
Business Address
George Sean E (Reporting) CIK: 0001627766 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39482 | Film No.: 201154431

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Issuer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks